Literature DB >> 16253597

Experience with statin use in patients with chronic hepatitis C infection.

Kimberly Gibson1, Joseph P Rindone.   

Abstract

We reviewed the liver enzymes of patients with chronic hepatitis C infection currently taking statin drugs. We found no significant elevation of liver enzymes during statin treatment of the 17 patients reviewed.

Entities:  

Mesh：

Substances：

Year:  2005        PMID： 16253597     DOI： 10.1016/j.amjcard.2005.06.071

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN： 0002-9149            Impact factor:   2.778


  12 in total

1.  Canadian Cardiovascular Society position statement--recommendations for the diagnosis and treatment of dyslipidemia and prevention of cardiovascular disease.

Authors:  Ruth McPherson; Jiri Frohlich; George Fodor; Jacques Genest
Journal:  Can J Cardiol       Date:  2006-09       Impact factor: 5.223

2.  Low-Density Lipoprotein Cholesterol Levels and Statin Treatment by HIV Status Among Multicenter AIDS Cohort Study Men.

Authors:  Anne K Monroe; Wei Fu; Michelle N Zikusoka; Lisa P Jacobson; Mallory D Witt; Frank J Palella; Lawrence A Kingsley; Wendy S Post; Todd T Brown
Journal:  AIDS Res Hum Retroviruses       Date:  2015-03-09       Impact factor: 2.205

Review 3.  Statins in the treatment of dyslipidemia in the presence of elevated liver aminotransferase levels: a therapeutic dilemma.

Authors:  Rossana M Calderon; Luigi X Cubeddu; Ronald B Goldberg; Eugene R Schiff
Journal:  Mayo Clin Proc       Date:  2010-04       Impact factor: 7.616

4.  Is statin therapy safe in patients with HIV/hepatitis C coinfection?

Authors:  Jeffrey S Stroup; Bryan Harris
Journal:  Proc (Bayl Univ Med Cent)       Date:  2010-04

5.  Use of statins in patients with liver disease.

Authors:  Sweta Tandra; Raj Vuppalanchi
Journal:  Curr Treat Options Cardiovasc Med       Date:  2009-08

6.  Statin therapy and serum transaminases among a cohort of HCV-infected veterans.

Authors:  Louise M Henderson; Shital Patel; Thomas P Giordano; Linda Green; Hashem B El-Serag
Journal:  Dig Dis Sci       Date:  2010-01       Impact factor: 3.199

7.  Atorvastatin does not improve liver biochemistries or Mayo Risk Score in primary biliary cirrhosis.

Authors:  Carmen M Stanca; Nancy Bach; Jorge Allina; Carol Bodian; Henry Bodenheimer; Joseph A Odin
Journal:  Dig Dis Sci       Date:  2008-04-05       Impact factor: 3.199

8.  Statins in the treatment of hepatitis C.

Authors:  Cristin Constantin Vere; Costin Teodor Streba; Liliana Streba; Ion Rogoveanu
Journal:  Hepat Mon       Date:  2012-06-30       Impact factor: 0.660

9.  Safety and efficacy evaluation of Ayurvedic treatment (Arjuna powder and Arogyavardhini Vati) in dyslipidemia patients: A pilot prospective cohort clinical study.

Authors:  Gajendra Kumar; Amita Srivastava; Surinder Kumar Sharma; Yogendra Kumar Gupta
Journal:  Ayu       Date:  2012-04

10.  Effect of calcium lactate supplementation on cholesterol concentration in patients with hyperlipidaemia and previous viral hepatitis: a preliminary report.

Authors:  G Andryskowski; J Chojnowska-Jezierska; M Broncel; M Barylski; M Banach
Journal:  Cardiovasc J Afr       Date:  2008 Mar-Apr       Impact factor: 1.167
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.